Medical expert of the article
New publications
Cervical metaplasia: what does it mean?
Last updated: 27.10.2025
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

Cervical metaplasia is a physiological process of replacing one cell type with another in the transformation zone, where the columnar epithelium of the cervical canal transitions to the stratified squamous epithelium of the outer cervix. Most often, this is called squamous cell metaplasia: "young" metaplastic cells gradually mature, becoming normal stratified squamous epithelium. This is a normal adaptation to the acidic environment of the vagina and hormonal fluctuations, not a disease. [1]
The transformation zone is where smear screening and colposcopy are performed: the vast majority of precancerous and cancerous changes in the cervix occur here, but metaplasia itself is not the same as precancerous changes. It is important to distinguish between "metaplasia" (cell type substitution) and "dysplasia" (atypical, precancerous changes). Misinterpretation leads to unnecessary interventions. [2]
The transformation zone may be completely visible during examination or partially "recessed" into the cervical canal; this determines the ease of observation and treatment methods for other pathologies (for example, dysplasia). The international IFCPC system distinguishes three types of transformation zone—this is an important "geography" for the gynecologist and colposcopist. [3]
Reservoir cells beneath the columnar epithelium are considered the source of metaplasia. They and the metaplastic epithelium are most susceptible to infection by high-risk human papillomavirus. Therefore, screening and vaccination remain the cornerstones of prevention, although metaplasia itself is benign. [4]
Table 1. Three concepts that are often confused
| Term | What does it mean | Clinical meaning |
|---|---|---|
| Ectopia/ectropion | The exit of the columnar epithelium to the outside | A normal variant, sometimes causing spotting; treat only if symptoms occur. |
| Metaplasia | Replacement of columnar epithelium with squamous epithelium | Transformation zone physiology, not precancerous |
| Dysplasia (precancer) | Atypical cells (CIN) | Requires guidance according to ASCCP guidelines |
Epidemiology
Metaplasia is a common condition in adolescents and women of reproductive age. During puberty, the transformation zone is active, and metaplasia is particularly intense; in most young women, the process culminates in the formation of "mature" squamous epithelium. In postmenopause, the transformation zone "retracts" into the canal, so metaplasia is less visible. [5]
Metaplasia occurs in a significant proportion of patients presenting for routine examinations. The IFCPC colposcopic terminology specifically identifies the "congenital transformation zone" and zone types (1-3) to standardize descriptions and improve data comparability across clinics and countries. This improves the accuracy of diagnosis of other pathologies that may occur in the same locations. [6]
The indirect "significance statistics" of metaplasia are reflected in the dysplasia data: it is the metaplastic cells and reserve cells of the transformation zone that are the target for persistent human papillomavirus infection, a key risk factor for cervical precancer and cancer. This explains why screening focuses on this zone. [7]
The incidence of associated benign findings—for example, nabothian cysts (mucus retention cysts)—is also high and is associated with metaplasia: new squamous epithelium "covers" the gland openings, and their secretions accumulate. Such cysts are usually small and harmless. [8]
Table 2. Transformation zone: how often and in whom it is visible
| Group | Features of the transformation zone | Comments |
|---|---|---|
| Teenagers/Young People | Wide, fully visible | Metaplasia is active; ectopia and Nabothian cysts are most often seen |
| Reproductive age | More commonly visible, variable size | "Regular" screening area |
| Perimenopause/postmenopause | Often partially in the channel | Often IFCPC type 3; more difficult to examine |
Reasons
The main cause of metaplasia is the adaptation of the cervical mucosa to vaginal conditions (acidic environment, microbiota, mechanical stress) and hormonal influences. Under the influence of estrogens and local factors, reserve cells are activated and give rise to squamous epithelium, which is more "resistant" to external conditions. This is biologically beneficial. [9]
Metaplasia is influenced by the position of the transformation zone. When columnar epithelium protrudes (ectopia), it is more quickly replaced by squamous epithelium—this is, in fact, metaplasia occurring "in plain sight." As hormonal stabilization occurs, ectopia decreases, and metaplasia "completes" the epithelium. [10]
Inflammation and microbiota changes can accelerate metaplasia (as a response to irritation) or accompany it. However, inflammation alone is not a prerequisite; metaplasia is often asymptomatic and is only detected upon examination. [11]
A number of rare variants of metaplasia affect the glandular epithelium of the cervical canal (for example, tubal metaplasia) - they are important in the differential diagnosis of the pathologist, but in routine practice they are almost always benign and do not require treatment in the absence of other signs. [12]
Table 3. What triggers metaplasia
| Trigger | Mechanism | Clinical significance |
|---|---|---|
| Acidic environment of the vagina | Adaptation of columnar epithelium | Formation of squamous epithelium |
| Hormonal fluctuations (puberty, pregnancy) | Expansion of the transformation zone | Metaplasia is becoming more active |
| Local irritants/inflammation | Stimulus to protect and "strengthen" the cover | May accompany symptoms |
| Ectopia | The exit of the columnar epithelium to the outside | "Visible" metaplasia |
Risk factors
Factors associated with visible metaplasia include young age, pregnancy, and the use of estrogen-containing contraceptives: in these conditions, the transformation zone is wider and closer to the outer surface. This is not a "disease risk," but an explanation for why metaplasia is more common in these conditions. [13]
Factors that increase the vulnerability of metaplastic cells include early sexual debut, multiple sexual partners, and the lack of barrier contraception—not because of the metaplasia itself, but because of the increased risk of persistence of the human papillomavirus, which is particularly prevalent in the metaplastic area. Screening and vaccination are important here. [14]
Chronic cervical inflammation (cervicitis), vaginal microbiota imbalance, and frequent invasive cervical procedures can lead to more active metaplasia and the development of nabothian cysts. These cysts result from the "covering" of the glandular openings by new squamous epithelium and usually require no treatment. [15]
In postmenopause, pronounced "visible" metaplasia is less common due to the shift of the transformation zone into the canal. However, if a postmenopausal patient experiences contact spotting or a "suspicious" cervix, this is not a sign of metaplasia – in this case, cancer-related suspicion and a low threshold for colposcopy apply. [16]
Table 4. Factors and their significance
| Factor | What's happening | What to do |
|---|---|---|
| Young age/pregnancy | Wide transformation zone | This is normal; observation |
| Barrier protection is not used | Higher risk of HPV persistence | Screening + vaccination |
| Cervicitis/dysbiosis | May increase symptoms | Treat according to protocols |
| Postmenopause | Zone in the canal, metaplasia is "hidden" | Low threshold for colposcopy in case of complaints |
Pathogenesis
The basic mechanism is the activation of reserve cells beneath the columnar epithelium. These cells divide and transform into squamous cells, forming "islands" of immature epithelium (immature metaplasia), which then mature into normal stratified squamous epithelium (mature metaplasia). This is a gradual, multi-stage process. [17]
Metaplastic and reserve cells are the primary "target" for highly oncogenic types of human papillomavirus. Persistent infection can lead to the development of precancerous changes (dysplasia), but metaplasia itself does not indicate precancerous progression. Therefore, screening and risk assessment are more important than attempts to "treat metaplasia." [18]
The closure of the gland openings by metaplastic epithelium explains the appearance of nabothian cysts: mucus does not exit and accumulates under the "lid," forming benign, usually small cysts. They can vary in size, sometimes reaching centimeters, but extremely rarely require intervention. [19]
On colposcopy, immature metaplasia can mimic faint acetowhite changes. It is for these situations that standardized terms and features (IFCPC) have been developed to distinguish benign processes from true precancerous changes and avoid overdiagnosis. [20]
Symptoms
Metaplasia itself is an asymptomatic condition. It is most often "noticed" during a routine examination. Sometimes, ectopia is present, and mucous and contact spotting may occur. These are manifestations of ectopia or associated inflammation, not metaplasia per se. [21]
Cervicitis (inflammation of the cervix) causes mucopurulent discharge, itching, burning, and contact bleeding. These symptoms require diagnosis and treatment consistent with those for sexually transmitted infections and bacterial vaginosis. Once the infection is eliminated, the subjective symptoms subside. [22]
Nabothian cysts associated with metaplasia usually cause no symptoms. Rarely, large cysts may cause a foreign body sensation or discomfort during intercourse. These situations are discussed individually and are usually treated with observation. [23]
Any persistent postcoital bleeding, especially after age 40, warrants a more thorough evaluation, as precancerous changes can occur among the many benign causes. It's important not to dismiss it as metaplasia. [24]
Table 5. When symptoms do not indicate metaplasia
| Complaint | A common cause | What to do |
|---|---|---|
| Mucous and "smearing" | Ectopia, cervicitis | Examination, tests for infections |
| Foul-smelling discharge | Bacterial vaginosis/Trichomonas | Laboratory confirmation and treatment |
| Persistent contact bleeding | Polyp/dysplasia/rarely cancer | Low threshold for colposcopy |
| "Ball" on the neck | Nabothian cyst | Observation; rarely - intervention |
Forms and stages
There are two types of squamous cell metaplasia: immature and mature. Immature metaplasia is characterized by a thin, still "young" layer that may appear light on colposcopy, with a mild reaction to vinegar; mature metaplasia is characterized by fully developed stratified squamous epithelium, clinically indistinguishable from the "native" epithelium. Both conditions are benign, but the former more often raises diagnostic questions. [25]
Anatomically, the transformation zone (IFCPC) is classified into the following types: Type 1 - completely visible on the outer surface; Type 2 - partially within the canal, but completely visible; Type 3 - part of the transformation zone extends into the canal and is not completely visible. This is important for the adequacy of colposcopy and the choice of treatment method, if required for another reason. [26]
Glandular variants of metaplasia also exist (for example, tubal metaplasia of the endocervix)—more often morphological findings in pathology. They can mimic other conditions at the microscopic level, but are usually clinically insignificant in the absence of suspicious features. [27]
The possible outcomes include the formation of nabothian cysts and the final maturation of the integument. There is no "obligatory" progression to dysplasia: the transition to precancerous development is associated not with metaplasia, but with the persistence of high-risk HPV. [28]
Table 6. Transformation zone types (IFCPC)
| Type | Where is the zone located? | Visibility during colposcopy | Practical significance |
|---|---|---|---|
| 1 | On the outer part of the neck | Fully visible | Convenient for observation and procedures |
| 2 | Partially in the channel | Fully visible | Technically feasible procedures |
| 3 | Significantly in the channel | Not fully visible | May require different tactics |
Complications and consequences
Metaplasia itself does not cause complications. Adverse events arise from misinterpretation (unnecessary "cauterization") or from missing concomitant pathology (dysplasia, polyp). The best way to avoid errors is to follow examination and screening standards. [29]
Nabothian cysts are a common "companion" of metaplasia. They are benign, rarely grow large, and rarely require intervention. Exceptions include severe discomfort or diagnostic doubt, when it is appropriate to remove the cyst and verify the diagnosis. [30]
With persistent high-risk human papillomavirus infection, precancerous changes may develop in the same metaplastic zone. This is a consequence of HPV infection, not metaplasia. Therefore, the emphasis is on vaccination and risk management according to current ASCCP guidelines. [31]
Misinterpretation of colposcopy (e.g., mistaking immature metaplasia for mild dysplasia) can lead to unnecessary procedures. The use of standardized IFCPC features reduces the likelihood of such errors and improves the consistency of findings. [32]
Table 7. What happens “against the background” of metaplasia and how to act
| Find | Risk | Tactics |
|---|---|---|
| Nabothian cyst | Short | Observation; symptom-based intervention |
| Immature metaplasia with a "light" reaction | Short | Colposcopy according to IFCPC, observation |
| Acetowhite areas with suspicious features | Higher | ASCCP/biopsy algorithm according to indications |
| Combination with high-risk HPV | Depends on the risk | ASCCP Risk Table Management |
Diagnostics
Metaplasia is most often a colposcopic and cytological finding. The physician evaluates the adequacy of the examination (type of transformation zone), the epithelial response to solutions, the boundaries, and the vascular pattern. If the findings are benign, observation is recommended; if the signs are questionable, a targeted biopsy is performed. [33]
A cytological smear may contain metaplastic cells—this is a normal indication that the sample reflects a transformation zone. The mere presence of metaplastic cells in a smear is not a warning sign. Interpretation depends on the presence of atypia. [34]
Modern screening programs rely on risk assessment based on HPV status and cytology. The ASCCP guidelines (2019) propose a risk-based approach: decisions are made based on the likelihood of precancer, not just the "name" of the finding. This protects against under- and over-diagnosis. [35]
Additional investigations (e.g., ultrasound) are not necessary for typical metaplasia. Exceptions apply to concomitant complaints (bleeding, suspected polyps, space-occupying lesions), when specialized methods are used. [36]
Table 8. Minimum diagnostic algorithm
| Step | Target | Comment |
|---|---|---|
| Examination/colposcopy | Identify the transformation zone and signs of "suspicion" | Classify the TZ type (1-3) |
| Cytology + HPV test | Precancer risk assessment | Solutions for ASCCP tables |
| Biopsy as indicated | Morphological verification | At the "red flags" |
| Observation | Avoid unnecessary procedures | Risk intervals |
Differential diagnosis
Metaplasia differs from dysplasia in that the cells mature normally, maintain proper architecture, and do not exhibit pronounced atypia. Colposcopic "weak" features without aggressive vascular patterns more often indicate metaplasia. When in doubt, a biopsy is the solution. [37]
Metaplasia must be distinguished from inflammatory changes (cervicitis), which cause contact bleeding and mucopurulent discharge. The diagnosis is confirmed by laboratory testing and treated causally. Symptoms resolve, but metaplasia remains as a physiological condition. [38]
Ectopia is not metaplasia, but rather a "background" against which metaplasia often occurs. Ectopia visually produces a red rim and contact discharge; it is treated only in cases of persistent complaints after infection and precancerous conditions have been ruled out. [39]
Rare glandular metaplasias of the endocervix (e.g., tubal metaplasia) are important for the pathologist to avoid confusing them with glandular neoplasia. Clinically, they rarely require action unless other suspicious features are present. [40]
Table 9. Metaplasia versus “similar” conditions
| State | What is similar? | What is the difference? |
|---|---|---|
| Dysplasia (precancer) | Acetowhite areas | Atypia and vascular signs; confirmed by biopsy |
| Cervicitis | Contact bleeding | Inflammatory discharge, laboratory confirmation |
| Ectopia | Red rim around the pharynx | Benign "everted" mucosa; metaplasia occurs against its background |
| Nabothian cyst | White "bubbles" on the neck | Retention of mucus under metaplastic epithelium |
Treatment
Metaplasia does not require treatment. It is a normal restructuring. The doctor's task is to explain the process, conduct age- and risk-based screening, and, if complaints are present, seek and treat the underlying cause (e.g., cervicitis, polyp, or severe symptomatic ectopia). [41]
If there is symptomatic ectopia (mucous and contact spotting) against the background of metaplasia, after ruling out infections and precancerous conditions, gentler methods can be discussed: chemical coagulation with silver nitrate for small areas, cryodestruction or diathermocoagulation for a larger area. These procedures reduce contact spotting; they are usually postponed during pregnancy. [42]
Nabothian cysts are not treated unless they cause discomfort or interfere with examination. Large, symptomatic cysts are treated with puncture/excision on an outpatient basis, as indicated; the material is usually benign. Imaging (ultrasound) is rarely necessary. [43]
"New" approaches are not aimed at eliminating metaplasia, but at standardizing routes: risk-based management according to ASCCP (decisions depend on a combination of cytology and HPV status) and a unified colposcopic terminology (IFCPC) (description of the transformation zone type, signs, and adequacy of examination). This reduces the number of unnecessary procedures and missed significant pathology. [44]
Table 10. What is actually being “treated” when they talk about “metaplasia”
| Situation | What are we doing? | Why |
|---|---|---|
| Asymptomatic metaplasia | Observation + screening | Physiology, does not require treatment |
| Symptomatic ectopia nearby | Gentle ablation as desired | Reduction of discharge/spotting |
| Cervicitis/dysbiosis | Etiotropic therapy | Complaints disappear, not "metaplasia" |
| Suspected precancer | Management according to ASCCP (including TZ excision) | Targeted cancer prevention |
Prevention
There is no specific prevention for metaplasia, nor is it necessary: it is a natural process in the transformation zone. Prevention of problems around metaplasia includes vaccination against the human papillomavirus, regular age-appropriate screening, and risk-based management according to the ASCCP. This approach reduces the likelihood of viral persistence and the development of precancerous lesions in the same area. [45]
Additional measures include taking care of vaginal health: protected sex with new/multiple partners, prompt diagnosis and treatment of cervicitis, and avoiding aggressive douching. This doesn't "slow down metaplasia," but it does reduce inflammation and the number of false alarms. [46]
Forecast
For the vast majority of women, the prognosis is excellent: metaplasia culminates in the formation of mature integumentary epithelium and does not affect fertility, sex life, or pregnancy. There is no "transition to cancer" by default—it is not precancerous. [47]
Long-term outcomes are influenced not by metaplasia, but by HPV status and screening adherence. With timely screening according to modern, risk-based guidelines, precancerous changes are identified and treated before cancer develops. Standardized approaches (ASCCP, IFCPC) make this safe and predictable. [48]
FAQ
- Is metaplasia a precancer?
No. This is normal cell replacement in the transformation zone. The risk of precancer is related to persistent HPV infection, not to the metaplasia itself. Follow screening. [49]
- The smear says "metaplastic cells." Is that bad?
No. This means that the smear was taken from the transformation zone. The assessment depends on the presence of atypia and HPV status. [50]
- Is it necessary to “cauterize” metaplasia?
No. They do not treat metaplasia, but rather the symptoms of ectopia, infection, or dysplasia identified according to standards. [51]
- Can metaplasia cause cysts on the cervix?
Yes, these are nabothian cysts—benign mucus "bubbles" that form when new squamous epithelium blocks the openings of the glands. They usually require no treatment. [52]
- Why do doctors pay so much attention to the transformation zone?
Because this is where both metaplasia (the norm) and most precancerous changes occur during HPV persistence. Screening and colposcopy "look" specifically here. [53]
Where does it hurt?
How to examine?
What tests are needed?
Who to contact?
More information of the treatment

